How do you counsel patients on safety and toxicity of delgocitinib?
2 Answers
Mednet Member
Dermatology · Case Western Reserve University
I request all eligible patients to complete the vaccines for herpes zoster prior to starting.
Delgocitinib has been reported to cause neutropenia, suggesting there is systemic absorption, so I do not recommend it for patients with a history of VTE.
I rarely see highly immunosuppressed patients with ...
Mednet Member
Dermatology · Dermatologists of Central States
I can't think of any situation, except maybe an active ongoing skin infection, in which I'd be hesitant to offer Anzupgo.
I do bring up that they are going to get information from the pharmacy that mentions some scary-sounding things that may be a risk with related medications taken as a pill, but t...